Display options
Cite
Tesse A, Andriantsitohaina R, Ragot T. PPARδ activity in cardiovascular diseases: A potential pharmacological target. PPAR Res. 2009;2009:745821doi: 10.1155/2009/745821.
Tesse, A., Andriantsitohaina, R., & Ragot, T. (2009). PPARδ activity in cardiovascular diseases: A potential pharmacological target. PPAR research, 2009745821. https://doi.org/10.1155/2009/745821
Tesse, Angela, et al. "PPARδ activity in cardiovascular diseases: A potential pharmacological target." PPAR research vol. 2009 (2009): 745821. doi: https://doi.org/10.1155/2009/745821
Tesse A, Andriantsitohaina R, Ragot T. PPARδ activity in cardiovascular diseases: A potential pharmacological target. PPAR Res. 2009;2009:745821. doi: 10.1155/2009/745821. Epub 2009 Mar 23. PMID: 19325917; PMCID: PMC2659552.
Copy Download .nbib Format: NLM
Share it on

PPAR Res. 2009;2009:745821. doi: 10.1155/2009/745821. Epub 2009 Mar 23.

PPARδ activity in cardiovascular diseases: A potential pharmacological target.

PPAR research

Angela Tesse, Ramaroson Andriantsitohaina, Thierry Ragot

Affiliations

  1. Laboratoire de Biologie Neurovasculaire Intégrée (LBNVI), UMR CNRS 6214/INSERM 771, Faculté de Médecine, Université d'Angers, rue Haute de Reculée, 49045 Angers Cedex 01, France. [email protected]

PMID: 19325917 PMCID: PMC2659552 DOI: 10.1155/2009/745821

Abstract

Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus. PPARα and PPARγ anti-inflammatory, antiproliferative and antiangiogenic properties in cardiovascular cells were extensively clarified in a variety of in vitro and in vivo models. In contrast, the role of PPARδ in cardiovascular system is poorly understood. Prostacyclin, the predominant prostanoid released by vascular cells, is a putative endogenous agonist for PPARδ, but only recently PPARδ selective synthetic agonists were found, improving studies about the physiological and pathophysiological roles of PPARδ activation. Recent reports suggest that the PPARδ activation may play a pivotal role to regulate inflammation, apoptosis, and cell proliferation, suggesting that this transcriptional factor could become an interesting pharmacological target to regulate cardiovascular cell apoptosis, proliferation, inflammation, and metabolism.

References

  1. J Biol Chem. 2000 Sep 8;275(36):28028-32 - PubMed
  2. J Biol Chem. 2002 Jun 14;277(24):21341-5 - PubMed
  3. Hum Mol Genet. 2006 Oct 1;15(19):2888-902 - PubMed
  4. J Cell Biochem. 2007 Nov 1;102(4):840-7 - PubMed
  5. J Clin Invest. 2001 Aug;108(3):391-7 - PubMed
  6. Biochimie. 2005 Jan;87(1):5-8 - PubMed
  7. J Clin Invest. 2007 Oct;117(10):2791-801 - PubMed
  8. J Cell Biol. 2001 Aug 20;154(4):799-814 - PubMed
  9. Circulation. 2005 Nov 15;112(20):3066-72 - PubMed
  10. Nature. 2000 May 25;405(6785):421-4 - PubMed
  11. Circulation. 2002 Apr 23;105(16):1962-9 - PubMed
  12. EMBO J. 2007 Aug 8;26(15):3686-98 - PubMed
  13. J Pharmacol Exp Ther. 2008 May;325(2):466-74 - PubMed
  14. Genes Dev. 2001 Dec 15;15(24):3263-77 - PubMed
  15. Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H161-6 - PubMed
  16. Basic Res Cardiol. 1992;87 Suppl 2:183-9 - PubMed
  17. Cancer Res. 2004 May 1;64(9):3162-70 - PubMed
  18. Exp Cell Res. 2008 Oct 15;314(17):3142-51 - PubMed
  19. Curr Atheroscler Rep. 2007 Jan;9(1):72-7 - PubMed
  20. Atherosclerosis. 2005 Jul;181(1):29-37 - PubMed
  21. J Pharmacol Exp Ther. 2008 Feb;324(2):539-47 - PubMed
  22. Circ Res. 2008 Jul 3;103(1):80-8 - PubMed
  23. Nat Med. 2004 Nov;10(11):1245-50 - PubMed
  24. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):359-65 - PubMed
  25. Mutat Res. 2000 Mar 17;448(2):121-38 - PubMed
  26. J Mol Cell Cardiol. 2004 Mar;36(3):363-70 - PubMed
  27. Circulation. 1996 Dec 1;94(11):2837-42 - PubMed
  28. Mol Cell Biochem. 1998 Nov;188(1-2):49-56 - PubMed
  29. Biochem Biophys Res Commun. 2003 Mar 7;302(2):415-20 - PubMed
  30. Diabetes Care. 1998 Jan;21(1):69-75 - PubMed
  31. J Clin Invest. 2001 Apr;107(7):917-23 - PubMed
  32. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):63-9 - PubMed
  33. J Clin Endocrinol Metab. 2004 Jun;89(6):2728-35 - PubMed
  34. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7355-9 - PubMed
  35. Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13275-80 - PubMed
  36. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4277-82 - PubMed
  37. Cancer Res. 2008 Aug 15;68(16):6578-86 - PubMed
  38. Cardiovasc Res. 2002 Jan;53(1):31-47 - PubMed
  39. Congest Heart Fail. 2005 Nov-Dec;11(6):322-4; quiz 325 - PubMed
  40. Trends Cardiovasc Med. 2000 Aug;10(6):238-45 - PubMed
  41. Cardiovasc Res. 2005 Mar 1;65(4):832-41 - PubMed
  42. Eur J Pharmacol. 2000 Nov 3;407(3):227-35 - PubMed
  43. Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3444-9 - PubMed
  44. Diabetes. 2000 Mar;49(3):346-55 - PubMed
  45. Circ Res. 2006 Jun 23;98(12):1538-46 - PubMed
  46. Hypertension. 2002 Feb;39(2):258-63 - PubMed
  47. Cell. 1999 Oct 29;99(3):335-45 - PubMed
  48. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7 - PubMed
  49. Stem Cells. 2007 Jul;25(7):1769-78 - PubMed
  50. Diabetes. 2006 Mar;55(3):622-32 - PubMed
  51. Science. 2003 Oct 17;302(5644):453-7 - PubMed
  52. J Biol Chem. 1997 Mar 21;272(12):8071-6 - PubMed
  53. Biochem Biophys Res Commun. 2007 Sep 7;360(4):821-7 - PubMed
  54. Heart Fail Rev. 2000 Oct;5(3):271-80 - PubMed
  55. FEBS Lett. 2005 Jul 4;579(17):3829-36 - PubMed
  56. Nature. 1990 Oct 18;347(6294):645-50 - PubMed
  57. Cardiovasc Res. 2006 Feb 1;69(2):440-9 - PubMed
  58. J Biol Chem. 2005 Apr 29;280(17):17464-71 - PubMed
  59. Circ Res. 2003 Nov 28;93(11):1026-8 - PubMed
  60. Cardiovasc Res. 2007 Aug 1;75(3):519-29 - PubMed
  61. J Biol Chem. 1999 Mar 5;274(10):6718-25 - PubMed
  62. J Lipid Res. 2005 May;46(5):1009-16 - PubMed
  63. Circ Res. 2007 Mar 16;100(5):e59-71 - PubMed
  64. J Clin Invest. 2001 Aug;108(3):399-405 - PubMed
  65. Curr Opin Lipidol. 2002 Oct;13(5):531-6 - PubMed
  66. Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1481-7 - PubMed
  67. EMBO J. 2002 Apr 15;21(8):1889-98 - PubMed
  68. J Cell Physiol. 2008 Feb;214(2):434-41 - PubMed
  69. Pharmacol Ther. 2006 Jun;110(3):371-85 - PubMed
  70. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):315-21 - PubMed
  71. Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5306-11 - PubMed
  72. Nat Rev Mol Cell Biol. 2002 May;3(5):349-63 - PubMed
  73. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4271-6 - PubMed
  74. Bioorg Med Chem Lett. 2003 May 5;13(9):1517-21 - PubMed
  75. Dis Colon Rectum. 2008 Mar;51(3):318-26; discussion 326-8 - PubMed
  76. J Clin Invest. 2007 Dec;117(12):3930-9 - PubMed
  77. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15924-9 - PubMed
  78. J Clin Invest. 2006 Mar;116(3):590-7 - PubMed
  79. J Clin Invest. 2004 Dec;114(11):1564-76 - PubMed
  80. Arch Biochem Biophys. 2007 Apr 1;460(1):25-32 - PubMed
  81. Circulation. 2008 Sep 2;118(10):1021-33 - PubMed
  82. Cell. 2003 Apr 18;113(2):159-70 - PubMed

Publication Types